Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Net Income: 2013-2025

Historic Net Income for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to $8.8 million.

  • Fortress Biotech's Net Income rose 133.03% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$75.2 million, marking a year-over-year increase of 36.67%. This contributed to the annual value of -$120.9 million for FY2024, which is 21.60% up from last year.
  • Fortress Biotech's Net Income amounted to $8.8 million in Q3 2025, which was up 124.62% from -$35.9 million recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Net Income ranged from a high of $8.8 million in Q3 2025 and a low of -$62.4 million during Q4 2021.
  • Moreover, its 3-year median value for Net Income was -$27.2 million (2024), whereas its average is -$28.3 million.
  • Per our database at Business Quant, Fortress Biotech's Net Income slumped by 159.68% in 2021 and then spiked by 133.03% in 2025.
  • Over the past 5 years, Fortress Biotech's Net Income (Quarterly) stood at -$62.4 million in 2021, then increased by 7.88% to -$57.4 million in 2022, then spiked by 49.54% to -$29.0 million in 2023, then rose by 9.21% to -$26.3 million in 2024, then soared by 133.03% to $8.8 million in 2025.
  • Its Net Income was $8.8 million in Q3 2025, compared to -$35.9 million in Q2 2025 and -$21.8 million in Q1 2025.